AI assistant
ABBOTT LABORATORIES — Director's Dealing 2008
Dec 17, 2008
29777_dirs_2008-12-17_150d678a-de24-4bca-bee9-1d823ad375e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-12-15
Reporting Person: Warmuth Michael J (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-12-15 | Common shares without par value | A | 3000 | $51.30 | Acquired | 37979 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 23 | Indirect |
Footnotes
F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Retention Restricted Stock Award Plan. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon reaching a minimum return on equity target. The award includes the right to have stock withheld for tax purposes.
F2: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan.
F3: Balance in the Abbott Laboratories Stock Retirement Trust as of December 15, 2008.